The Pharmaphorum ASCO 2018 Daily Bulletin | Latest News RSS feed

The Pharmaphorum ASCO 2018 Daily Bulletin - Latest News


The pharmaphorum ASCO 2018 daily bulletin

All too often pharma companies are accused of putting shareholders before their patients and society as a whole. But Germany’s Merck KGaA is trying to change all this with its Future Insight Prize, a ... read more

Otonomy's $525 Million Dive Is Fennec's Good Fortune

Otonomy has been pursuing label expansion for Swimmer’s Ear (through sNDA, expect in 2018), and for Pediatric Patients with ... been presented at leading oncology conferences such as SIOP, ASCO, and E... read more

La Jolla Doctor Elected to American Society of Clinical Oncology Board

LA JOLLA, CA – Michael Kosty, medical director of Scripps Cancer Center at Scripps Green Hospital and Scripps Clinic, has been elected to the board of directors of the American Society of Clinical Onc... read more

Looking for another news?


Safe Handling of Hazardous Drugs: ASCO Standards

The ASCO Expert Panel endorses the best practices for safe handling of hazardous drugs as issued by the Occupational Safety and Health Administration, US Pharmacopeia Chapter 800, and Oncology Nursing ... read more


Drugs score big wins against lung, prostate, breast cancers

Here are highlights from the world's largest cancer meeting, the American Society of Clinical Oncology conference in Chicago. Janssen Biotech's Zytiga improved survival and delayed cancer growth for 1... read more

Ask a Mexican on Bland Mexican Beer

The Mexican-American community is the most adversely affected by the influx of illegals. Only the politicians have any gain from lumping all Hispanics into the Latino category. Are proud, hardworking ... read more

Charles Hunt Joins BulletinHealthcare as Publisher

"Bulletin Healthcare ... specific daily medical news to nearly 600,000 members of the nation's most prestigious medical associations (American Medical Association, American College of Cardiology, Amer... read more

ASCO 2018 – Tuesday 5th June: Tesaro developing checkpoint combo

Data released at ASCO 2018 is from TOPACIO, a phase 1/2 trial in ovarian cancer or triple negative breast cancer (TNBC). Following dose finding in phase 1, a Zejula (niraparib) pill was administered d... read more

A first: All respond in a blood cancer study

In a second study of nearly two dozen patients, everyone above a certain dose responded. Experts at an American Society of Clinical Oncology conference in Chicago, where the results were announced Mon... read more

20 New Job Openings Around Old Town Alexandria

We've rounded up some of the listings in and around Old Town Alexandria from employers like Alexandria City Public Schools and the American Society of Clinical Oncology. If you're looking for somethin... read more

Major Changes in Head and Neck Staging for 2018

The rationale and emerging data supporting these changes are discussed in this article and the accompanying oral presentation at the 2018 ASCO Annual Meeting. Three major changes were made to the stag... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us